New York State Teachers Retirement System continued to hold its stake in shares of PharMerica Corp. (NYSE:PMC) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,103 shares of the company’s stock at the end of the second quarter. New York State Teachers Retirement System’s holdings in PharMerica Corp. were worth $2,543,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in PMC. TIAA CREF Investment Management LLC boosted its stake in shares of PharMerica Corp. by 32.5% in the first quarter. TIAA CREF Investment Management LLC now owns 156,998 shares of the company’s stock valued at $3,471,000 after buying an additional 38,479 shares during the period. Prudential Financial Inc. raised its position in PharMerica Corp. by 37.5% in the first quarter. Prudential Financial Inc. now owns 265,139 shares of the company’s stock valued at $5,863,000 after buying an additional 72,260 shares in the last quarter. BlackRock Group LTD raised its position in PharMerica Corp. by 13.9% in the first quarter. BlackRock Group LTD now owns 40,754 shares of the company’s stock valued at $901,000 after buying an additional 4,983 shares in the last quarter. BlackRock Fund Advisors raised its position in PharMerica Corp. by 2.2% in the first quarter. BlackRock Fund Advisors now owns 2,146,542 shares of the company’s stock valued at $47,460,000 after buying an additional 46,633 shares in the last quarter. Finally, BlackRock Institutional Trust Company N.A. raised its position in PharMerica Corp. by 2.1% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 815,898 shares of the company’s stock valued at $18,040,000 after buying an additional 17,086 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors.
Shares of PharMerica Corp. (NYSE:PMC) traded down 1.49% during mid-day trading on Friday, reaching $27.11. 183,588 shares of the company traded hands. The stock has a market capitalization of $834.01 million, a price-to-earnings ratio of 28.01 and a beta of 0.88. PharMerica Corp. has a 52-week low of $19.79 and a 52-week high of $35.81. The company’s 50 day moving average is $26.93 and its 200 day moving average is $25.32.
PharMerica Corp. (NYSE:PMC) last posted its earnings results on Tuesday, August 9th. The company reported $0.47 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.47. The company had revenue of $519.60 million for the quarter, compared to analyst estimates of $508.31 million. PharMerica Corp. had a return on equity of 10.00% and a net margin of 1.44%. PharMerica Corp.’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.48 earnings per share. On average, equities analysts forecast that PharMerica Corp. will post $2.01 earnings per share for the current year.
Separately, Zacks Investment Research upgraded PharMerica Corp. from a “sell” rating to a “hold” rating in a report on Friday, September 23rd. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the stock. PharMerica Corp. presently has an average rating of “Buy” and a consensus price target of $31.57.
PharMerica Corp. Company Profile
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States.
Want to see what other hedge funds are holding PMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PharMerica Corp. (NYSE:PMC).
Receive News & Ratings for PharMerica Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharMerica Corp. and related companies with MarketBeat.com's FREE daily email newsletter.